Comparative In-Vitro Quality Assessment of Commercially Available Isosorbide Dinitrate 10 mg Tablet Formulations

Isosorbide dinitrate (ISDN) is a well-known organic nitrate that is frequently used to treat heart failure and angina pectoris because of its potent vasodilatory activity. The pharmacological profile, mechanisms of action, therapeutic uses, and new developments in formulation techniques are the main topics of this review article's thorough assessment of ISDN. The medication's effects on nitric oxide pathway modulation, myocardial oxygen supply-demand balance, and preload and afterload reduction in cardiovascular diseases are highlighted. The article also discusses safety concerns and limitations such as tolerance development, and clinical evidence for its effectiveness. In order to improve therapeutic results, novel therapeutic strategies including combination regimens and medication administration are also covered. Overall, this review highlights the ongoing importance of ISDN in cardiovascular medication and suggests possible avenues for further study and therapeutic application.

Authors

Publication Details

Journal
International Journal of Pharmaceutics and Drug Analysis
Published
2026-11-13
DOI
https://doi.org/10.47957/ijpda.v14i3.758
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative In-Vitro Quality Assessment of Commercially Available Isosorbide Dinitrate 10 mg Tablet Formulations

Naga Santhosh Reddy Satti, Veerendra Kumar D, Sai Sri Mounika Tanapathi, Bunny Nuthulapati et al.
International Journal of Pharmaceutics and Drug Analysis
Analytical Methods in Pharmaceuticals
article

Comparative In-Vitro Quality Assessment of Commercially Available Isosorbide Dinitrate 10 mg Tablet Formulations

Naga Santhosh Reddy Satti, Veerendra Kumar D, Sai Sri Mounika Tanapathi, Bunny Nuthulapati, Sri Satya Ratna Navya Lakshmi Chakka, Varshitha Satti
article en

Abstract

Isosorbide dinitrate (ISDN) is a well-known organic nitrate that is frequently used to treat heart failure and angina pectoris because of its potent vasodilatory activity. The pharmacological profile, mechanisms of action, therapeutic uses, and new developments in formulation techniques are the main topics of this review article's thorough assessment of ISDN. The medication's effects on nitric oxide pathway modulation, myocardial oxygen supply-demand balance, and preload and afterload reduction in cardiovascular diseases are highlighted. The article also discusses safety concerns and limitations such as tolerance development, and clinical evidence for its effectiveness. In order to improve therapeutic results, novel therapeutic strategies including combination regimens and medication administration are also covered. Overall, this review highlights the ongoing importance of ISDN in cardiovascular medication and suggests possible avenues for further study and therapeutic application.

International Journal of Pharmaceutics and Drug Analysis
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon